HTLV type 1, 2, recombinant protein from E. coli
E. coli derived recombinant 100kDa protein, (Purified/Coating; EIA), strain: BL21 DE3
Purified by proprietary chromatographic technique. Protein is > 95% pure as determined by 10% PAGE (coomassie staining) and RP-HPLC
Lyophilized from a solution containing 25mM Tris, 250mM Glycine and 0. 1% SDS.
2-8°C short term, -20°C long term
The Human T-lymphotropic virus Type I (HTLV-1) is a human RNA retrovirus that is known to cause a type of cancer, referred to as adult T-cell leukemia and lymphoma, and a demyelinating disease called HTLV-I associated myelopathy/Tropical spastic paraparesis (HAM/TSP). HTLV-I is one of a group of closely related primate T lymphotropic viruses (PTLVs). Members of this family that infect humans are called Human T-lymphotropic viruses, and the ones that infect old-world primates are called Simian T-lymphotropic viruses. To date, four types of HTLVs (HTLV-I, HTLV-II, HTLV-III, and HTLV-IV) and four types of STLVs (STLV-I, STLV-II, STLV-III, and STLV-V) have been identified. The HTLVs are believed to originate from intraspecies transmission of STLVs. The original name for HIV, the virus that causes AIDS, was HTLV-III; this term is no longer in use.
HTLV-1/HTLV-2; Human T-lymphotropic virus; Simian T-lymphotropic virus; HTLV-1; HTLV-2; Human T-lymphotropic virus 2; HTLV-II; Human T-lymphotropic virus Type I/Human T-lymphotropic virus Type II; Human T-lymphotropic virus Type I; Human T-lymphotropic vi